FDA
-
-
-
-
-
-
-
Cesca Therapeutics (KOOL) Granted 510(k) Clearance to Market Its AXP II AutoXpress Platform for Clinical Cord Blood Banking
-
-
-
-
-
-
-
Cesca Prices $5.5 Million Public Offering
-
-
-
-
-
-
-
Cesca Therapeutics (KOOL) IDE Supplement for Phase III Clinical Trial Approved by FDA
-
-
323,762 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

